198 related articles for article (PubMed ID: 31902218)
1. Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study.
Flygare L; Al-Ubaedi A; Öhman W; Mo SJ
Acta Radiol; 2020 Sep; 61(9):1196-1204. PubMed ID: 31902218
[TBL] [Abstract][Full Text] [Related]
2. Chest radiography or chest CT plus head and neck CT versus
Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
[TBL] [Abstract][Full Text] [Related]
3. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
Kim SY; Roh JL; Yeo NK; Kim JS; Lee JH; Choi SH; Nam SY
Ann Oncol; 2007 Oct; 18(10):1698-703. PubMed ID: 17716985
[TBL] [Abstract][Full Text] [Related]
4. Choice of imaging modality for pre-treatment staging of head and neck cancer impacts TNM staging.
Mur T; Sambhu KM; Mahajan A; Payabvash S; Fernandez J; Edwards HA
Am J Otolaryngol; 2020; 41(6):102662. PubMed ID: 32858370
[TBL] [Abstract][Full Text] [Related]
5. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Senft A; de Bree R; Hoekstra OS; Kuik DJ; Golding RP; Oyen WJ; Pruim J; van den Hoogen FJ; Roodenburg JL; Leemans CR
Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977
[TBL] [Abstract][Full Text] [Related]
6. Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and
Rohde M; Nielsen AL; Johansen J; Sørensen JA; Nguyen N; Diaz A; Nielsen MK; Asmussen JT; Christiansen JM; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2017 Dec; 58(12):1919-1924. PubMed ID: 28572489
[TBL] [Abstract][Full Text] [Related]
7. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Kitagawa Y; Nishizawa S; Sano K; Sadato N; Maruta Y; Ogasawara T; Nakamura M; Yonekura Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
[TBL] [Abstract][Full Text] [Related]
8. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
9.
Pedraza S; Ruiz-Alonso A; Hernández-Martínez AC; Cabello E; Lora D; Pérez-Regadera JF
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):154-159. PubMed ID: 30655026
[TBL] [Abstract][Full Text] [Related]
10. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699
[TBL] [Abstract][Full Text] [Related]
11. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Roh JL; Ryu CH; Choi SH; Kim JS; Lee JH; Cho KJ; Nam SY; Kim SY
J Nucl Med; 2007 Feb; 48(2):240-6. PubMed ID: 17268021
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Al-Bulushi NK; Abouzied ME
Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of
Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
[No Abstract] [Full Text] [Related]
15. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
[TBL] [Abstract][Full Text] [Related]
16. [
Linz C; Brands RC; Hackenberg S; Hartmann S; Iring T; Hohm J; Haug L; Kertels O; Kircher M; Dierks A; Buck AK; Brumberg J; Lapa C
J Craniomaxillofac Surg; 2022 Aug; 50(8):671-676. PubMed ID: 35794029
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
[TBL] [Abstract][Full Text] [Related]
18. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073
[TBL] [Abstract][Full Text] [Related]
19. Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.
Westergaard-Nielsen M; Rohde M; Godballe C; Eriksen JG; Larsen SR; Gerke O; Nguyen N; Nielsen MK; Nielsen AL; Thomassen A; Asmussen JT; Diaz A; Høilund-Carlsen PF; Bjørndal K
Ann Nucl Med; 2019 Aug; 33(8):554-563. PubMed ID: 31102059
[TBL] [Abstract][Full Text] [Related]
20. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.
Ilcheva M; Nikolova P; Hadzhiyska V; Mladenov K
Neoplasma; 2022 Jul; 69(4):948-956. PubMed ID: 35471980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
